Corporate Information And Statement Of Ifrs Compliance [Abstract]

Xspray Pharma - Filing #679275

Concept	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	—	Xspray Pharma AB	—
Domicile of entity	—	Solna	—
Legal form of entity	—	AB	—
Country of incorporation	—	Sverige	—
Address of entity's registered office	—	Scheeles väg 2 171 65 Solna, Sverige	—
Principal place of business	—	Sverige	—
Description of nature of entity's operations and principal activities	—	Xspray Pharma AB är ett produktutvecklingsföretag med flera produktkandidater i klinisk utveckling	—
Name of parent entity	—	Xspray Pharma AB	—
Statement of IFRS compliance [text block]	—	Koncernens finansiella rapporter har upprättats*<	—
Disclosure of uncertainties of entity's ability to continue as going concern [text block]	—	Risker och osäkerhetsfaktorer Affärsrisker*	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories	43 781 SEK	—	8 552 SEK
Current trade payables	12 472 SEK	—	14 786 SEK
Disclosure of material accounting policy information [text block]	—	Valuta och rapporteringsvalutaModerbolagets funktionella valuta*	—
Explanation of sources of estimation uncertainty with significant risk of causing material adjustment	—		—